V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033555 | 210013132 | 1.7 | 77.4 | Curative (C) | 2013-03-22 | 2014-08-28 | PONATINIB | N | null | 210038940 | ERWINIA ASPARAGINASE |
| 210033556 | 210013134 | 1.55 | 20.9 | Palliative (P) | 2016-05-17 | 2016-07-11 | Procarbazine | N | N | 210038943 | PROCARBAZINE |
| 210033557 | 210013143 | 1.77 | 98 | Palliative (P) | 2017-06-18 | 2017-06-18 | Methotrexate High Dose (3g/m2) | 2 | N | 210039017 | RIALTO TRIAL |
| 210033558 | 210013144 | 0 | 120.8 | Disease modification (D) | 2019-06-17 | 2019-07-06 | CYCLOPHOSPHAMIDE | 2 | N | 210039036 | CYCLOPHOSPHAMIDE |
| 210033559 | 210013151 | null | null | null | 2015-06-26 | 2016-01-29 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 210039055 | CARBOPLATIN + VINCRISTINE |
| 210033560 | 210013154 | null | null | null | 2013-07-10 | 2013-08-15 | CHOP - 21 days | N | N | 210039065 | CARBOPLATIN + ETOPOSIDE |
| 210033561 | 210022261 | 1.79 | 16.6 | null | null | 2014-01-01 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | null | 210039110 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210033562 | 210013172 | 1.72 | 53.2 | Curative (C) | 2018-02-13 | 2018-06-24 | Pentostatin | 01 | N | 210039146 | BEVACIZUMAB |
| 210033563 | 210022267 | 1.66 | 47.45 | Palliative (P) | 2016-11-26 | 2017-07-01 | Dasatinib | Y | N | 210039158 | DASATINIB |
| 210033564 | 210022270 | 1.67 | null | Curative (C) | 2019-01-24 | 2019-06-30 | CNS LGG 2004 03 vinc weekly+ carbo | N | null | 210039177 | CARBOPLATIN + VINCRISTINE |
| 210033565 | 210013182 | 1.55 | null | null | 2017-06-15 | 2017-06-23 | Cyclophosphamide+Fludara+TBI Allo | N | Y | 210039186 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210033566 | 210013188 | 0 | 50.5 | Curative (C) | 2014-12-06 | 2014-12-15 | Bevacizumab | N | N | 210039212 | UKALL XII |
| 210033567 | 210013190 | 1.83 | 53.6 | Disease modification (D) | 2016-12-29 | 2017-02-14 | Bendamustine + prednisolone | N | N | 210039213 | CARBOPLATIN + ETOPOSIDE |
| 210033568 | 210022278 | 1.78 | null | Curative (C) | 2015-11-11 | 2015-11-11 | CHOP - 21 days | 2 | N | 210039241 | BEVACIZUMAB |
| 210033569 | 210022280 | 0 | 45.2 | Curative (C) | 2016-05-06 | 2016-05-06 | LOMUSTINE + PROCARBAZINE | N | N | 210039263 | LOMUSTINE + PROCARBAZINE |
| 210033570 | 210013197 | 1.51 | 61.8 | Adjuvant (A) | 2015-04-19 | 2015-05-02 | CLADRIBINE | N | N | 210039270 | CLADRIBINE |
| 210033571 | 210022284 | 1.85 | 113 | Curative (C) | 2015-01-27 | 2015-03-17 | LOMUSTINE + PROCARBAZINE | 02 | N | 210039276 | LOMUSTINE + PROCARBAZINE |
| 210033572 | 210013203 | 1.67 | 79.5 | Palliative (P) | 2016-10-18 | 2016-11-22 | LOMUSTINE + PROCARBAZINE | 2 | N | 210039294 | LOMUSTINE + PROCARBAZINE |
| 210033573 | 210013205 | 1.72 | 43.8 | Disease modification (D) | 2017-07-19 | 2018-04-25 | CYCLOPHOSPHAMIDE | N | N | 210039296 | CYCLOPHOSPHAMIDE |
| 210033574 | 210013210 | null | 102.3 | Palliative (P) | 2016-06-05 | 2016-06-14 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 210039323 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210033575 | 210013211 | 0 | 85 | Palliative (P) | 2015-09-10 | 2016-01-15 | Vinblastine weekly | N | Y | 210039328 | VINBLASTINE |
| 210033576 | 210013225 | 1.72 | 79.3 | Curative (C) | 2013-11-13 | 2014-02-02 | LOMUSTINE + PROCARBAZINE | null | null | 210039382 | LOMUSTINE + PROCARBAZINE |
| 210033577 | 210013231 | 1.58 | 93.8 | Curative (C) | 2018-09-20 | 2018-09-25 | CNS LGG 2004 03 vinc weekly+ carbo | 02 | N | 210039421 | CARBOPLATIN + VINCRISTINE |
| 210033578 | 210013237 | 1.6 | 56.3 | Disease modification (D) | 2016-04-30 | 2016-04-30 | PONATINIB | N | N | 210039433 | INOTUZUMAB OZOGAMICIN |
| 210033579 | 210013243 | 1.65 | 62.5 | Disease modification (D) | 2017-07-28 | 2017-10-13 | Inotuzumab Ozogamicin | N | N | 210039456 | CHOP |
| 210033580 | 210013248 | 0 | 67.4 | Palliative (P) | 2015-09-23 | 2015-09-23 | CNS Low Grade Glioma Vinblastine | 02 | N | 210039493 | VINBLASTINE |
| 210033581 | 210022316 | 1.79 | 94.2 | null | 2017-07-16 | 2017-07-16 | IDELALISIB | Y | N | 210039566 | RIALTO TRIAL |
| 210033582 | 210013256 | 1.63 | null | Adjuvant (A) | 2018-05-01 | 2018-12-25 | CNS Low Grade Glioma Vinblastine | null | N | 210039592 | VINBLASTINE |
| 210033583 | 210013258 | 0 | 0 | Curative (C) | 2015-09-18 | 2015-09-18 | Methotrexate High Dose (3g/m2) | N | N | 210039601 | UKALL XII |
| 210033584 | 210031462 | 1.73 | 67.3 | Curative (C) | 2017-07-03 | 2017-08-14 | Cyclophosphamide TBI Allograft | N | null | 210039622 | CYCLOPHOSPHAMIDE |
| 210033585 | 210013265 | null | 96.4 | Curative (C) | 2013-03-01 | 2014-08-01 | Cyclophosphamide+Fludara+TBI Allo | N | N | 210039646 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210033586 | 210013270 | 0 | 35.8 | Curative (C) | null | 2018-01-17 | CLADRIBINE | 02 | N | 210039685 | CLADRIBINE |
| 210033587 | 210013278 | 1.75 | 19 | null | 2013-12-16 | 2013-12-20 | Vinblastine | 2 | null | 210039712 | VINBLASTINE |
| 210033588 | 210013283 | 1.66 | 93.4 | Curative (C) | 2019-07-31 | 2019-10-20 | Bevacizumab 7.5mg/kg | N | N | 210039734 | CARBOPLATIN + ETOPOSIDE |
| 210033589 | 210013284 | 1.8 | 101.6 | Palliative (P) | 2011-11-19 | 2013-12-22 | Cyclophosphamide + Vincristine | 02 | N | 210039746 | CHLORAMBUCIL + OFATUMUMAB |
| 210033590 | 210022339 | 1.78 | null | Curative (C) | 2015-12-30 | 2016-01-05 | Pentostatin | null | N | 210039757 | UKALL XII |
| 210033591 | 210013296 | null | 93.8 | Palliative (P) | 2018-12-19 | 2019-03-08 | PONATINIB | Y | N | 210039787 | INOTUZUMAB OZOGAMICIN |
| 210033592 | 210028011 | null | 71.5 | Palliative (P) | 2014-05-15 | 2017-07-02 | CHLORAMBUCIL + OFATUMUMAB | N | N | 210039810 | IDELALISIB |
| 210033593 | 210013314 | 1.67 | 12.3 | Curative (C) | 2016-07-30 | 2016-10-10 | BENDAMUSTINE | N | N | 210039899 | INOTUZUMAB OZOGAMICIN |
| 210033594 | 210036186 | 1.7 | 101 | Disease modification (D) | null | 2014-12-04 | IDELALISIB | N | N | 210039963 | RIALTO TRIAL |
| 210033595 | 210013336 | 1.82 | 79.4 | Disease modification (D) | 2014-07-28 | 2014-11-26 | UKALL XII Maintenance (3 months) | N | N | 210040004 | BEVACIZUMAB |
| 210033596 | 210013347 | 0 | 19 | null | 2014-10-28 | 2016-01-01 | Bevacizumab 15mg/kg | 02 | N | 210040057 | BENDAMUSTINE |
| 210033597 | 210013355 | 0 | 73.7 | null | 2013-08-20 | 2013-09-18 | LOMUSTINE + PROCARBAZINE | N | N | 210040080 | LOMUSTINE + PROCARBAZINE |
| 210033598 | 210028029 | 1.88 | 98.7 | Curative (C) | 2018-09-02 | 2018-09-02 | CYCLOPHOSPHAMIDE | N | N | 210040113 | CYCLOPHOSPHAMIDE |
| 210033599 | 210036187 | 1.69 | 90.5 | Palliative (P) | 2015-12-29 | 2015-12-29 | UKALL XII Induction Phase 1 | N | N | 210040136 | CHOP |
| 210033600 | 210031481 | 1.77 | 9.3 | Palliative (P) | 2014-02-20 | 2014-07-21 | Procarbazine | Y | N | 210040158 | PROCARBAZINE |
| 210033601 | 210022378 | 1.82 | 73 | Palliative (P) | 2017-02-23 | 2017-02-23 | LOMUSTINE + PROCARBAZINE | 2 | N | 210040197 | LOMUSTINE + PROCARBAZINE |
| 210033602 | 210013378 | 1.77 | 78.1 | Palliative (P) | 2016-03-20 | 2016-03-20 | Bevacizumab 15mg/kg | N | N | 210040336 | IDELALISIB |
| 210033603 | 210033657 | 1.65 | 54 | Adjuvant (A) | 2015-10-13 | 2015-10-13 | CNS LGG 2004 03 vinc weekly+ carbo | 2 | N | 210040383 | CARBOPLATIN + VINCRISTINE |
| 210033604 | 210013382 | 1.6 | 26.45 | Adjuvant (A) | 2014-10-01 | 2015-01-18 | CHLORAMBUCIL + OFATUMUMAB | N | N | 210040386 | NELARABINE |